Retinopathy


Article Author:
William Stone
Bhupendra Patel
Hajira Basit


Article Editor:
Baby Salini


Editors In Chief:
Shane Havens
Jim Wang
Koushik Tripathy


Managing Editors:
Avais Raja
Orawan Chaigasame
Khalid Alsayouri
Kyle Blair
Radia Jamil
Erin Hughes
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Navid Mahabadi
Hussain Sajjad
Steve Bhimji
Muhammad Hashmi
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Abbey Smiley
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beenish Sohail
Hajira Basit
Phillip Hynes
Sandeep Sekhon


Updated:
4/25/2019 9:12:56 AM

Introduction

The retina contains photoreceptor cells that function in the process of visual transduction, i.e., transforming light signals to nerve impulses eventually transmitted from the optic nerve to the brain forming an image.  There are two types of photoreceptor cells, rod, and cones. The cone cells are for color vision and the rod cells, which function well in low light conditions, i.e., scotopic vision.  The macula is the small part of the retina responsible for central vision (see Figure), and it has a very high density of cone cells thereby providing high visual acuity.  Retinopathy is not a specific disease but refers to pathological alterations to the retina resulting from a variety of causes, environmental conditions, and genetic factors.  The retina is especially susceptible to the effects of oxidative stress damage since it has the highest content of polyunsaturated fatty acids of any tissue as well as the highest oxygen consumption.[1]

In mammals, the retina is supplied with oxygen and nutrients by the retinal and choroidal circulatory systems, and most major causes of retinopathy involve damage to these systems.[2] The retinal circulation supplies the inner (towards the center of the eye) half of the retina and the choroidal circulation supplies the outer half of the retina. Light must pass through the retinal capillaries (and some neuronal layers) before striking the photoreceptors (see Figure). The choroid lies behind the retinal pigment epithelium (RPE).  The RPE, the macula, and anterior segment of the optic nerve depend on the choroidal circulation for oxygen and nutrients (see Figure). Lack of sufficient blood flow in the retinal circulation can lead to optic neuropathy and vision loss.  Rupture of the retinal capillaries can lead to bleeding into the vitreous humor (vitreous hemorrhage) and vision loss.[3]  

Etiology

Diabetic retinopathy (DR) is the commonest form of retinopathy as well as the most common cause of adult vision loss and blindness.[4]  Poor glycemic control and hypertension contribute to DR. Diabetic retinopathy consists of two types, a proliferative form (PDR) and a nonproliferative form (NPDR).  NPDR is caused by microaneurysms in the retinal circulation resulting in leakage of fluids and blood into the retina.  When this leakage occurs in the macula, the result is macular edema with subsequent impairment of vision. PDR is the more advanced type of diabetic retinopathy and results from the proliferation (neovascularization) of leaky retinal vasculature. Ocular neovascularization is a major factor causing a shift from the non-proliferative form of diabetic retinopathy to the more pernicious proliferative form.  The new and fragile vessels can cause a vitreous hemorrhage thereby preventing light from reaching the photoreceptors.

Hypertensive retinopathy is also very prevalent and important since its prime driving factor, hypertension is present in about one-third of USA adults and is a risk factor for cardiovascular disease.[5]  Either chronic or acute episodes of hypertension can contribute to hypertensive retinopathy.  Chronic hypertension causes a constriction of the retinal vasculature (i.e., an increase in vascular tone) which can eventually result in damage to vascular endothelial cells.   Endothelial cell damage can, in turn, result in the final “sclerotic” phase of hypertensive retinopathy. 

Retinopathy of prematurity (ROP) is a major worldwide cause of blindness and vision loss in premature, low birth weight and extremely low birth weight newborns.  Although rare, ROP “like” signs can also occur is full-term newborns.[6]  ROP is an “oxidative stress disease” of neonatology and has been etiologically linked to the necessity for some premature infants to receive supplemental oxygen therapy.[7][8]

Vascular endothelial growth factor (VEGF) plays a key role in many retinopathies. Hypoxia induces VEGF expression, and VEGF stimulates angiogenesis.[8]  Oxygen therapy for ROP results in transient hyperoxia as well as an initial suppression of VEGF which, in turn, results in incomplete and abnormal retinal vasculature as well as endothelial cell death.  Subsequent closure of the retinal vasculature results in hypoxia with an increased VEGF synthesis resulting in neovascularization.

Age-related macular degeneration (AMD) results in impairment of central (but not peripheral) vision and is caused by damage to the macula.  There are two major variants of AMD, “wet” (or exudative) and “dry” (or atrophic) with “dry” accounting for about 80 to 90% of all AMD cases.  Although accounting for only the remaining 10 to 20% of all AMD cases, wet AMD is responsible for about 90% of severe vision loss.[9] The intracellular accumulation of oxidized lipid pigments (lipofuscin) in the retinal pigment epithelium (RPE) is known to correlate with AMD.[10] The RPE is a monolayer of cells behind the photoreceptors (see Figure) and functions to phagocytize outer photoreceptor segments that are shed daily. The etiology of AMD is an active area of research.  Lipofuscin accumulation resulting from an impairment of RPE phagocytosis has been thought to be important in AMD pathogenesis, and recent work supports this view.[11]

Similarly, the extracellular accumulation of drusen between the RPE and the Bruch’s membrane is also a risk factor for AMD.   Drusen, like lipofuscin, is a complex chemical mixture containing oxidatively modified proteins.  Some of the oxidatively modified proteins in drusen crosslink to oxidative products of docosahexaenoic (22:6n3) which is polyunsaturated fatty acid with a high content in rod outer segment phospholipids.[12]

Epidemiology

All of the retinopathies reviewed here are leading worldwide causes of vision loss. Hypertensive retinopathy, diabetic retinopathy, and AMD will be increasingly important due to aging populations with increased incidences of hypertension and diabetes.  Advances in the treatment of prematurity have increased survival rates in ROP, thereby contributing to increased ROP incidence.   Moreover, most retinopathies have a multifactorial etiologies with lifestyle, environmental factors, and genetics all playing important roles.  

About one-third of individuals with diabetes have signs of diabetic retinopathy.[13]  Both hyperglycemia and hypertension are established risks for diabetic retinopathy.   Inflammation and oxidative stress may also be risk factors for diabetic retinopathy.[13]

Hypertensive retinopathy is present in about two-thirds of all hypertensive outpatients with hypertensive duration, age, and systolic blood pressure all being significant risks.[14]  In contrast, gender and BMI (body mass index) are not significant risk factors for hypertensive retinopathy. 

Age-Related macular degeneration (AMD) is a prime cause of blindness in the elderly (older than 60 years old) and is less prevalent in people with African ancestry.  Early AMD is more prevalent in people with European ancestry compared to Asians.[15]

A very large-scale and comprehensive study (the USA and Canada) on the incidence of retinopathy of prematurity shows that at least 40% of at-risk-premature infants develop some stage of ROP but that most of these newborns improve without treatment.[16]  About 8 to 10% do, however, develop severe ROP and these cases occur primarily in newborns with a birth weight under 1250 g.

Evaluation

The evaluation of most retinopathies relies on ophthalmoscopy (also called funduscopy) which can also evaluate the optic disc and the vitreous humor.  Eye dilation is necessary for accurate assessment of any retinopathy.  Ophthalmoscopy comes in few varieties, i.e., direct, indirect, slit-lamp and pantropic.  A direct ophthalmoscope is a small handheld device with its own source of illumination and is typically used most in a primary care setting.  In patients with mild hypertension, direct ophthalmoscopy has been found to have a significant inter- and intra-observer variability.[17]

An indirect ophthalmoscope is also a handheld device but has a separate source of illumination from a headband and is almost universally performed by an ophthalmologist.  The indirect method provides a wider field of vision for the back of the eye than direct ophthalmoscopy. Pan ophthalmoscopy is a newer form of direct ophthalmoscopy that can be used without pupil dilation while providing a broad view of the fundus.  Slit-lamp ophthalmoscopy utilizes a fixed high-intensity light source and a handheld lens and is typically performed by an ophthalmologist. 

In addition to diagnosing retinopathies, ophthalmoscopy may be useful in diagnosing Alzheimer disease.[18] Individuals with Alzheimer disease exhibit a higher level of drusen accumulation in their peripheral retinas compared to controls.  Although preliminary, this finding could be significant since it could provide a non-invasive method for evaluating Alzheimer disease which is not currently available.

Hypertensive retinopathies are best identified using a standardized examination of fundus photographs as compared to clinical ophthalmoscopy.[17]  A variety of staging paradigms for retinopathies have been developed that rely heavily on ophthalmoscopy.  The Keith-Wagener-Barker (KWB) system is widely used to grade hypertensive retinopathy.   This system divides hypertensive retinopathy into four grades:

  1. Hypertension with mild narrowing of the retinal arteries and no symptoms present
  2. Hypertension with more pronounced arterial narrowing and generally no symptoms present
  3. Overt signs of retinal damage, e.g., retinal hemorrhage, cotton wool spots, “copper wiring” of arterioles and symptoms may be present
  4. Grade 3 criteria plus papilledema, i.e., swelling of the optic disc and symptoms are present - the symptoms can include vision loss, blurred or double vision, and headaches

The KWB system has come under criticism for not being able to clearly distinguish grade 1 from grade 2 and an alternative system; the Mitchel-Wong system has been proposed with combines the grade 1 and grade 2 of the KWB system into one grade.[19]

As mentioned above, diabetic retinopathy falls into two primary classes, proliferative and non-proliferative.  The Scottish grading system is a more elaborate and detailed protocol for grading diabetic retinopathy, and it relies on a digital retinal photograph (27418727). A clinical classification system was developed for AMD that emphasizes drusen accumulation.[20]

Retinopathy of prematurity (ROP) has five stages.  Blood vessel growth can be mildly abnormal (stage 1), moderately abnormal (stage 2) or severely abnormal (stage 3 and above).  In stage 4 the retina is partially detached, and in stage 5 the retina is completely detached which defines the end stage of this disease.

Treatment / Management

The vast majority of newborns with retinopathy of prematurity have a mild form of the disease (stages 1 and 2), and their condition improves without any treatment.  Careful monitoring and delivery of oxygen therapy have reduced oxygen toxicity.  About 8 to 10% of newborns with ROP require medical intervention such as laser therapy or cryotherapy.  

Lifestyle modifications are usually the first tier of preventative treatment for most of the retinopathies described above.  These modifications could include weight loss, dietary changes such as portion control, aerobic exercise (e.g., greater than 130 steps per min), smoking cessation, reduction/elimination of alcohol and maintaining normal lipoprotein-cholesterol levels.   For hypertensive retinopathy, excellent, cost-effective hypertensive medications are readily available.  For diabetic retinopathy, glycemic control is a crucial factor.[21]  For proliferative diabetic retinopathy, exercise requires particular caution due to the increased risk of retinal hemorrhage and retinal detachment.  Any exercise that increases blood pressure should be avoided.  Metformin, a medication used to treat type 2 diabetes, slows the development of diabetic retinopathy.[22]  AMD specific treatments include dietary supplementation with antioxidant nutrients, injection of ranibizumab, implantation of a  miniature telescope in patients with end-stage macular degeneration. Ranibizumab is a monoclonal antibody fragment that inhibits VEGF.  There are several maternal lifestyle risk factors for premature or low birth weight infants that could be modified to help prevent ROP, e.g., smoking cessation, early care during pregnancy, dealing with substance abuse disorders and minimizing stress.

Enhancing Healthcare Team Outcomes

Patients with vision changes typically have their first encounter with the nurse practitioner, general physician, pediatrician or internist. In each case, it is essential to refer the patient to an ophthalmologist for definitive work up. The role of the primary care providers is to emphasize to the patient the need to stop smoking, maintain healthy body weight, eat a healthy diet and wear sunglasses when going out.

Retinopathy, irrepsective of its underlying cause, is best managed by an interprofessional team combining physicians (both GP and ophthalmologist), and specilaty trained ophthlmology nursing, communicating with the patient and other health team members to bring about optimal patient care and results.


  • Image 6805 Not availableImage 6805 Not available
    Contributed by Pranav Modi
Attributed To: Contributed by Pranav Modi

Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Retinopathy - Questions

Take a quiz of the questions on this article.

Take Quiz
The Keith-Wagener-Barker system is used to classify which of the following?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Patients with diabetic retinopathy are at risk for retinal bleeding and loss of vision. Which of the following activities would be acceptable in such a patient?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A patient presents with blurred vision, diabetes, and hypertension. You suspect diabetic retinopathy could be a cause of the blurred vision. Which of the following is true?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Patient presents with sudden and complete loss of vision in her left eye since this morning. Previously, she had no visual symptoms. Her past medical history is notable for type 1 diabetes and hypertension. A dilated funduscopic examination shows bloody vitreous, new blood vessel growth on the right optic nerve, as well as, throughout the posterior pole. Visual acuity is 20/20 for the right eye and light perception in the left eye. Which of the following is the best treatment plan for this patient?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Retinopathy - References

References

Stone WL,Farnsworth CC,Dratz EA, A reinvestigation of the fatty acid content of bovine, rat and frog retinal rod outer segments. Experimental eye research. 1979 Apr;     [PubMed]
Conart JB,Berrod JP, [Non-traumatic vitreous hemorrhage]. Journal francais d'ophtalmologie. 2016 Feb;     [PubMed]
Torpy JM,Glass TJ,Glass RM, JAMA patient page. Retinopathy. JAMA. 2007 Aug 22;     [PubMed]
Hendrick AM,Gibson MV,Kulshreshtha A, Diabetic Retinopathy. Primary care. 2015 Sep;     [PubMed]
Harjasouliha A,Raiji V,Garcia Gonzalez JM, Review of hypertensive retinopathy. Disease-a-month : DM. 2017 Mar;     [PubMed]
Ratra D,Akhundova L,Das MK, Retinopathy of prematurity like retinopathy in full-term infants. Oman journal of ophthalmology. 2017 Sep-Dec;     [PubMed]
Stone WL,Shah D,Hollinger SM, Retinopathy of prematurity: an oxidative stress neonatal disease. Frontiers in bioscience (Landmark edition). 2016 Jan 1;     [PubMed]
Söderström F,Normann E,Holmström G,Larsson E,Ahlsson F,Sindelar R,Ågren J, Reduced rate of treated retinopathy of prematurity after implementing lower oxygen saturation targets. Journal of perinatology : official journal of the California Perinatal Association. 2019 Mar;     [PubMed]
Al-Zamil WM,Yassin SA, Recent developments in age-related macular degeneration: a review. Clinical interventions in aging. 2017;     [PubMed]
Katz ML, Potential role of retinal pigment epithelial lipofuscin accumulation in age-related macular degeneration. Archives of gerontology and geriatrics. 2002 May-Jun;     [PubMed]
Inana G,Murat C,An W,Yao X,Harris IR,Cao J, RPE phagocytic function declines in age-related macular degeneration and is rescued by human umbilical tissue derived cells. Journal of translational medicine. 2018 Mar 13;     [PubMed]
Crabb JW,Miyagi M,Gu X,Shadrach K,West KA,Sakaguchi H,Kamei M,Hasan A,Yan L,Rayborn ME,Salomon RG,Hollyfield JG, Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proceedings of the National Academy of Sciences of the United States of America. 2002 Nov 12;     [PubMed]
Lee R,Wong TY,Sabanayagam C, Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye and vision (London, England). 2015;     [PubMed]
Erden S,Bicakci E, Hypertensive retinopathy: incidence, risk factors, and comorbidities. Clinical and experimental hypertension (New York, N.Y. : 1993). 2012;     [PubMed]
Jonas JB,Cheung CMG,Panda-Jonas S, Updates on the Epidemiology of Age-Related Macular Degeneration. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2017 Nov-Dec;     [PubMed]
Quinn GE,Ying GS,Bell EF,Donohue PK,Morrison D,Tomlinson LA,Binenbaum G, Incidence and Early Course of Retinopathy of Prematurity: Secondary Analysis of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study. JAMA ophthalmology. 2018 Dec 1;     [PubMed]
Wong TY,Mitchell P, Hypertensive retinopathy. The New England journal of medicine. 2004 Nov 25;     [PubMed]
Csincsik L,MacGillivray TJ,Flynn E,Pellegrini E,Papanastasiou G,Barzegar-Befroei N,Csutak A,Bird AC,Ritchie CW,Peto T,Lengyel I, Peripheral Retinal Imaging Biomarkers for Alzheimer's Disease: A Pilot Study. Ophthalmic research. 2018;     [PubMed]
Aissopou EK,Papathanassiou M,Nasothimiou EG,Konstantonis GD,Tentolouris N,Theodossiadis PG,Papaioannou TG,Sfikakis PP,Protogerou AD, The Keith-Wagener-Barker and Mitchell-Wong grading systems for hypertensive retinopathy: association with target organ damage in individuals below 55 years. Journal of hypertension. 2015 Nov;     [PubMed]
Ferris FL 3rd,Wilkinson CP,Bird A,Chakravarthy U,Chew E,Csaky K,Sadda SR, Clinical classification of age-related macular degeneration. Ophthalmology. 2013 Apr;     [PubMed]
Chatziralli IP, The Role of Glycemic Control and Variability in Diabetic Retinopathy. Diabetes therapy : research, treatment and education of diabetes and related disorders. 2018 Feb;     [PubMed]
Zhang Y,Chen F,Wang L, Metformin inhibits development of diabetic retinopathy through microRNA-497a-5p. American journal of translational research. 2017;     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Surgery-Ophthalmology. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Surgery-Ophthalmology, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Surgery-Ophthalmology, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Surgery-Ophthalmology. When it is time for the Surgery-Ophthalmology board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Surgery-Ophthalmology.